Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Capital Economics stated in a report that the Bangko Sentral ng Pilipinas has limited room for further interest rate hikes, and is very likely to reverse course next year.

Capital Economics stated in a report that the Bangko Sentral ng Pilipinas has limited room for further interest rate hikes, and is very likely to reverse course next year.

老虎证券老虎证券2026/06/29 05:01
Show original
After a slowdown in growth in the first quarter, the economic recovery of the Philippines may be very gradual, partly due to the initial impact of the global energy shock. Amid rising energy prices, inflation has also surged significantly in recent months. Currently, Capital Economics expects the Philippines central bank to raise interest rates by at least another 25 basis points to 5.00%, as the bank is monitoring the threat posed by high inflation. However, concerns about the weakness of the Philippine economy may prompt the central bank to adopt a wait-and-see approach in the near future, and it may begin cutting interest rates from early 2027.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The 160 Threshold Under Threat Again! Yen Nears "Intervention Red Line," Tokyo May Spend Money Again to Rescue the Currency

The Japanese yen is approaching the 1 USD = 160 JPY level. Atsushi Mimura commented that the movement is "too fast." The US-Japan interest rate gap may widen further, and Japanese officials have hinted at being ready to intervene again.

智通财经•2026/11/12 02:26

Blackstone (BX.US) injects up to $1.5 billion, providing fresh ammunition for Pfizer (PFE.US) in the weight-loss drug race

Pfizer announced on Wednesday that it has reached an agreement with Blackstone to obtain up to $1.5 billions in funding to support the development of its experimental monthly obesity treatment drug.

智通财经•2026/11/12 01:07